Overview
Saba Capital Management, L.P., which holds approximately ten percent of BlackRock ESG Capital Allocation Term Trust (NASDAQ: ECAT), reduced its stake through two separate stock sales executed at the end of March 2026. The firm sold a combined total of 262,345 shares across transactions on March 30 and March 31, realizing $3,594,044 from the disposals.
Transaction details
On March 30, Saba Capital sold 37,868 shares at $13.52 per share. After that sale, the firm’s position stood at 22,246,640 shares. The following day, March 31, Saba sold an additional 224,477 shares at $13.73 per share, bringing its remaining holding to 22,022,163 shares. The combined proceeds from the two transactions were $3,594,044.
Market context
At the time of reporting, ECAT was trading at $13.89, a price noted as being close to the fund’s 52-week low of $13.35. The fund also carries a reported dividend yield of 24.15%.
Regulatory disclosure
The sales were disclosed in a Form 4 filing with the U.S. Securities and Exchange Commission. The filing bears the signatures of Zachary Gindes, acting on behalf of Saba Capital Management, L.P., and Boaz Weinstein.
Investor information note
The filing and market facts above summarize the insider selling activity and current price and yield metrics for ECAT. The article notes that InvestingPro subscribers have access to five additional tips about ECAT’s financial health and performance metrics.
Takeaway
In late March 2026, Saba Capital reduced its stake in BlackRock ESG Capital Allocation Term Trust via two transactions that together totaled $3.59 million. The sales were formally reported in an SEC Form 4 and occurred while ECAT traded close to its 52-week low and offered a substantial dividend yield.